Cancer Institute Hospital of JFCR
Heavyweight! First ADC Drug For Refractory Ovarian Cancer Receives Accelerated FDA Approval
New Treatment Effective In Up To 73% Of Multiple Myeloma Patients!
New Study: Nmn Supplementation Activates Longevity Proteins To Reduce Stem Cell Senescence And Restore Mitochondrial Function
There Is No Cure For Alzheimer's Disease And Death Usually Occurs Within Ten Years Of Diagnosis, So The Best Option Now Is To Prevent It Early.
More Significant Survival Benefit For Non-Small Cell Lung Cancer Patients Under 55 Years Of Age, Also Using Immunotherapy!
